Abstract
The cardiac neurohormone B-type natriuretic peptide (BNP) can predict mortality in patients with acute coronary syndromes, but levels are usually measured within days of the start of symptoms. In this Practice Point Saihari Sadanandan discusses Grabowskiet al.'s study exploring the link between BNP levels on admission for ST-elevation myocardial infarction, short-term mortality and angiographic success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
